The Use of the Prevena Incision Management System to Reduce Post-operative Cesarean Delivery Wound Complications
Withdrawn before enrolling
Conditions studied: Pregnancy
In brief
Aim 1: Assess the effectiveness of the Prevena Incision Management System in decreasing postoperative surgical site infections in the obese parturient undergoing non-emergent cesarean delivery. Aim 2: Assess patient satisfaction after using the Prevena Incision Management System following a non-emergent cesarean delivery. Our overall long term goal is to reduce morbidity and incidence of surgical site infection (SSI) in obese parturient who undergo non-emergent cesarean delivery.
Key facts
- Study ID
- NCT01661348
- Run by
- University of Oklahoma
- People needed
- 0
- Starts
- 2012-07-01
- Expected to finish
- 2014-07-01
- Last updated by the study team
- 2013-10-16
Who can join
Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women greater than or equal to 18-years-of-age having a non-emergent Cesarean delivery, primary or repeat procedure, without evidence of active infection at the time of the procedure
- Patient with BMI ≥ 30 kg/m2 at the time of hospital admission
- Patient able to provide informed consent for study
- Patient able to complete follow-up
You may not qualify if…
- Males
- Females under the age of 18
- Known sensitivity to silver due to the presence of silver in the skin interface layer of the Prevena
- Patients unable to consent
- Patients in active labor
- Patients with a diagnosis of preterm premature rupture of membranes
- Patients with known or suspected infection at the time of Cesarean delivery
- Patients with a contraindication to use of the Prevena Incision Management System
Where it is running
- University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.